| A rectal cancer organoid platform to study individual responses to chemoradiation K Ganesh, C Wu, KP O’Rourke, BC Szeglin, Y Zheng, CEG Sauvé, ... Nature medicine 25 (10), 1607-1614, 2019 | 364 | 2019 |
| Tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer Z Zhang, WR Karthaus, YS Lee, VR Gao, C Wu, JW Russo, M Liu, ... Cancer Cell 38 (2), 279-296. e9, 2020 | 166 | 2020 |
| Mismatch repair–deficient rectal cancer and resistance to neoadjuvant chemotherapy A Cercek, G Dos Santos Fernandes, CS Roxburgh, K Ganesh, S Ng, ... Clinical Cancer Research 26 (13), 3271-3279, 2020 | 144 | 2020 |
| Bioreducible hyperbranched poly (amido amine) s for gene delivery J Chen, C Wu, D Oupicky Biomacromolecules 10 (10), 2921-2927, 2009 | 137 | 2009 |
| Effect of innate glutathione levels on activity of redox-responsive gene delivery vectors DS Manickam, J Li, DA Putt, QH Zhou, C Wu, LH Lash, D Oupický Journal of controlled release 141 (1), 77-84, 2010 | 110 | 2010 |
| Loss of CHD1 promotes heterogeneous mechanisms of resistance to AR-targeted therapy via chromatin dysregulation Z Zhang, C Zhou, X Li, SD Barnes, S Deng, E Hoover, CC Chen, YS Lee, ... Cancer cell 37 (4), 584-598. e11, 2020 | 107 | 2020 |
| An important player in brine shrimp lethality bioassay: The solvent C Wu Journal of advanced pharmaceutical technology & research 5 (1), 57, 2014 | 92 | 2014 |
| SMAD4 loss in colorectal cancer patients correlates with recurrence, loss of immune infiltrate, and chemoresistance I Wasserman, LH Lee, S Ogino, MR Marco, C Wu, X Chen, J Datta, ... Clinical Cancer Research 25 (6), 1948-1956, 2019 | 90 | 2019 |
| Epithelial Smad4 deletion up-regulates inflammation and promotes inflammation-associated cancer AL Means, TJ Freeman, J Zhu, LG Woodbury, P Marincola-Smith, C Wu, ... Cellular and Molecular Gastroenterology and Hepatology 6 (3), 257-276, 2018 | 58 | 2018 |
| Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model C Wu, XL Jiang, HW Shen, AM Yu Biochemical pharmacology 78 (6), 617-624, 2009 | 51 | 2009 |
| Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N, N-dimethyltryptamine metabolism and pharmacokinetics HW Shen, C Wu, XL Jiang, AM Yu Biochemical pharmacology 80 (1), 122-128, 2010 | 42 | 2010 |
| Evaluation of pharmacokinetics of bioreducible gene delivery vectors by real-time PCR QH Zhou, C Wu, DS Manickam, D Oupický Pharmaceutical research 26, 1581-1589, 2009 | 31 | 2009 |
| Cyclic RGD-targeting of reversibly stabilized DNA nanoparticles enhances cell uptake and transfection in vitro QH Zhou, YZ You, C Wu, Y Huang, D Oupický Journal of drug targeting 17 (5), 364-373, 2009 | 27 | 2009 |
| Opposing influence of intracellular and membrane thiols on the toxicity of reducible polycations C Wu, J Li, Y Zhu, J Chen, D Oupický Biomaterials 34 (34), 8843-8850, 2013 | 24 | 2013 |
| Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insights OI Alatise, GC Knapp, A Sharma, WK Chatila, OA Arowolo, O Olasehinde, ... Nature Communications 12 (1), 6821, 2021 | 23 | 2021 |
| Synthesis of bisethylnorspermine lipid prodrug as gene delivery vector targeting polyamine metabolism in breast cancer Y Dong, Y Zhu, J Li, QH Zhou, C Wu, D Oupický Molecular pharmaceutics 9 (6), 1654-1664, 2012 | 23 | 2012 |
| 对苯二甲酰氯合成 程永浩， 邹小毛， 任雪玲， 吴超， 杨华铮 化学试剂 25 (2), 118-118, 2003 | 22 | 2003 |
| A claudin-based molecular signature identifies high-risk, chemoresistant colorectal cancer patients S Gowrikumar, M Primeaux, K Pravoverov, C Wu, BC Szeglin, CEG Sauve, ... Cells 10 (9), 2211, 2021 | 19 | 2021 |
| Sensitisation of cancer cells to radiotherapy by serine and glycine starvation M Falcone, AH Uribe, V Papalazarou, AC Newman, D Athineos, ... British Journal of Cancer 127 (10), 1773-1786, 2022 | 18 | 2022 |
| Colorectal cancer develops inherent radiosensitivity that can be predicted using patient-derived organoids KS Hsu, M Adileh, ML Martin, V Makarov, J Chen, C Wu, S Bodo, ... Cancer research 82 (12), 2298-2312, 2022 | 17 | 2022 |
